Search

Date 2016 Author/Creator Minini, Pascal

1. Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials. (15th November 2016)

Authors:
Farnier, Michel; Gaudet, Daniel; Valcheva, Velichka; Minini, Pascal; Miller, Kathryn; Cariou, Bertrand
Journal:
International journal of cardiology
Issue:
Volume 223(2016)
Page Start:
750
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials. (15th November 2016)

Authors:
Farnier, Michel; Gaudet, Daniel; Valcheva, Velichka; Minini, Pascal; Miller, Kathryn; Cariou, Bertrand
Journal:
International journal of cardiology
Issue:
Volume 223(2016)
Page Start:
750
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control. Issue 24 (13th December 2016)

Authors:
Ray, Kausik K.; Ginsberg, Henry N.; Davidson, Michael H.; Pordy, Robert; Bessac, Laurence; Minini, Pascal; Eckel, Robert H.; Cannon, Christopher P.
Journal:
Circulation
Issue:
Volume 134:Issue 24(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search